Nonclinical pharmacodynamics, pharmacokinetics and safety profiles of anti-human transferrin receptor antibody-fused Nsulfoglucosamine sulfohydrolase for mucopolysaccharidosis type IIIAMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Foxp3-Positive Regulatory T Cells Contribute to Antifibrotic Effects in Renal Fibrosis via an Interleukin-18 Receptor Signaling PathwayFRONTIERS IN MEDICINEIF32020-12-027OAAI
The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical CareLIFE-BASELIF3.42020-10-295OAAI
Clinical and functional significance of STEAP4-splice variant in CD14+ monocytes in patients with rheumatoid arthritisCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82017-11-167OAAI
TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expressionSCIENTIFIC REPORTSIF3.92016-12-2014OAAI
CTRP6 is an endogenous complement regulator that can effectively treat induced arthritisNATURE COMMUNICATIONSIF15.72015-09-2568OAAI
Specific overexpression of tumour necrosis factor--induced protein (TNFAIP)9 in CD14+CD16- monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3CLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82015-05-1512OAAI
Regulation of Intestinal IgA Responses by Dietary Palmitic Acid and Its MetabolismJOURNAL OF IMMUNOLOGYIF3.42014-08-1553OAAI
Antigen-specific over-expression of human cartilage glycoprotein 39 on CD4+CD25+ forkhead box protein 3+ regulatory T cells in the generation of glucose-6-phosphate isomerase-induced arthritisCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82014-07-099OAAI
CLINICAL ASPECTS AND PATHOGENICITY OF ANTI-CYCLIC CITRULLINATED GLUCOSE-6-PHOSPATE ISOMERASE PEPTIDE (CCG) ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
B cells play a crucial role as antigen-presenting cells and collaborate with inflammatory cytokines in glucose-6-phosphate isomerase-induced arthritisCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82008-11-2018OAAI